Last updated: June 12, 2026
Back to directoryPerinatal early-warning platform that uses FDA-cleared fetal heart rate analytics and supervised machine learning to support clinician review of maternal and fetal monitoring signals.
Hospital L&D programs that need continuous maternal-fetal surveillance, standardized alerting, and command-center visibility while keeping bedside assessment and patient-management decisions clinician-led.
Compare within workflow: Clinical operations and revenue cycle · comparison shortlist · source index
Product-specific review. These product-specific signals summarize what the cited sources imply before treating PeriGen PeriWatch Vigilance as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Treat as regulated perinatal monitoring software and high-risk clinical decision support; match local use to the exact cleared algorithm, gestational-age scope, intended-use statement, warning language, and clinician-adjunct boundary. |
|---|---|
| Privacy | Review EMR and central-monitor data flows, fetal tracings, maternal vitals, mobile access, identity provider integration, PHI retention, support access, audit logging, BAA terms, cybersecurity documentation, and model-change controls. |
| Evidence | Use the FDA summary, vendor responsible-AI materials, research pages, and local pilot data to test performance across tracing quality, monitor vendors, preterm cases, alert burden, clinician response, and maternal-fetal safety outcomes. |
| Workflow | Best governed as continuous L&D situational awareness with predefined nurse, OB, anesthesia, triage, postpartum, command-center, escalation, downtime, and incident-review workflows rather than as a standalone interpretation tool. |
PeriGen describes PeriWatch Vigilance as an automated early warning and clinical decision-support system for labor and delivery that monitors maternal vital signs, fetal heart rate patterns, contractions, and labor progress. PeriGen says Vigilance uses supervised machine learning for fetal heart rate pattern interpretation and contraction detection and incorporates FDA-cleared algorithms. FDA 510(k) K241009 identifies PeriCALM Patterns 3.0 as Class II perinatal monitoring software for adjunctive antepartum or intrapartum obstetrical monitoring at or beyond 32 weeks gestation, with warnings that patient management should not be based solely on the software's annotations or summaries.
Not for: Standalone fetal monitoring interpretation, autonomous obstetric decisions, unsupported gestational ages or monitoring systems, emergency response without clinical protocols, or deployments without OB, nursing, IT, privacy, and risk-management governance.
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.
FDA-cleared patient surveillance and predictive analytics system that uses EHR-derived vital signs, labs, and nursing assessments to trend patient acuity through the Rothman Index.
Oncology workflow automation platform that uses AI to turn unstructured pathology, radiology, clinical document, and EMR data into actionable patient-management worklists.
AI clinical insights platform that surfaces patient history context and documentation before physician review.
Real-time clinical intelligence platform with an FDA-cleared continuous sepsis flagging device and broader inpatient risk workflow modules.